CCND1 POSITIVE
Clinical trials for CCND1 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new CCND1 POSITIVE trials appear
Sign up with your email to follow new studies for CCND1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise against tough blood cancer
Disease control OngoingThis study tests a two-drug combination (ibrutinib and rituximab) in people with mantle cell lymphoma that has returned or not responded to treatment, or in older adults newly diagnosed. The goal is to shrink or control the cancer. About 113 participants will receive the drugs to…
Matched conditions: CCND1 POSITIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Triple-Drug attack aims to wipe out mantle cell lymphoma
Disease control OngoingThis phase II trial tests whether combining three drugs—bendamustine, obinutuzumab, and venetoclax—can improve outcomes for people with untreated mantle cell lymphoma. Bendamustine and venetoclax are chemotherapy drugs that kill or stop cancer cells from growing, while obinutuzum…
Matched conditions: CCND1 POSITIVE
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC